Adult haemophagocytic syndrome

Clicks: 460
ID: 111140
2014
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #17 of 161 articles by views in Lancet (London, England)

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 161 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Haemophagocytic syndromes (haemophagocytic lymphohistiocytosis) have a wide range of causes, symptoms, and outcomes, but all lead to a hyperinflammatory response and organ damage--mainly reported in paediatric patients, but reports of adult presentation are increasing. Analysis of the genetic and mo …
Reference Key
m2014lancetadult Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Ramos-Casals M;Brito-Zerón P;López-Guillermo A;Khamashta MA;Bosch X;;
Journal Lancet (London, England)
Year 2014
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/24290661
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't adult Incidence pmid:24290661 doi:10.1016/s0140-6736(13)61048-x manuel ramos-casals pilar brito-zerón xavier bosch global health* lymphohistiocytosis hemophagocytic* / diagnosis hemophagocytic* / epidemiology hemophagocytic* / etiology hemophagocytic* / therapy

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.